NDUFAF4

protein-coding

NADH:ubiquinone oxidoreductase complex assembly factor 4, the group of Mitochondrial respiratory chain complex assembly factors

Gene summary

NADH:ubiquinone oxidoreductase (complex I) catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q) in the first step of the mitochondrial respiratory chain, resulting in the translocation of protons across the inner mitochondrial membrane. This gene encodes a complex I assembly factor. Mutations in this gene are a cause of mitochondrial complex I deficiency. [provided by RefSeq, Oct 2009]

Previous symbols:
  • C6orf66

MANE transcript

NM_014165.4

Inheritance

AR

ClinVar variants

P:3U:40B:22

Top phenotype

Mitochondrial complex I deficiency, nuclear type 15

gnomAD constraint

pLI —, LoF o/e 0.15

Max pathogenic AF

—

Genomic locus

chr6:96,889,315-96,897,891

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~8.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

mitochondrial complex I deficiency, nuclear type 15STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0032620

Submitter: PanelApp Australia

mitochondrial diseaseDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0044970

Submitter: ClinGen

The relationship between *NDUFAF4* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 6, 2023. The *NDUFAF4* gene (previously known as *C6ORF66*) encodes the NADH:ubiquinone oxidoreductase (complex I) assembly factor 4. Defects of this protein lead to complex I deficiency. The *NDUFAF4* gene was first reported in relation to autosomal recessive primary mitochondrial disease in 2008 (PMID: 18179882). While various names have been given to the constellation of features seen in those with *NDUFAF4*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFAF4* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *NDUFAF4* was first curated by this GCEP for its association with Leigh syndrome spectrum (LSS) on February 12, 2020 (SOP v7), with a final classification of Limited. This current curation for the association with primary mitochondrial disease includes the single case included in the LSS curation. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included four variants in four cases from four publications (PMIDs: 18179882, 30369941, 28853723, 32949790), as well as segregation data from the first large family reported (PMID: 18179882). Affected individuals typically presented in the neonatal period with severe lactic acidosis leading to neonatal mortality or severe neurological involvement for surviving children. Additional features include intrauterine growth restriction, lactic acidosis, LSS disorder, encephalopathy, seizures, dystonia, limited spontaneous movements, myopathy, hypertrophic cardiomyopathy, sensorineural hearing loss, optic atrophy, and failure to thrive. Complex I deficiency is noted in muscle and/or skin fibroblasts. Loss of function resulting in a complex I assembly defect is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function and functional alteration in patient cells (PMIDs: 18179882, 33340416). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed since the first proposal of the association. No convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 6, 2023 (SOP Version 9).

mitochondrial complex I deficiencySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0100133

Submitter: Orphanet

Leigh syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0009723

Submitter: ClinGen

The relationship between NDUFAF4 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of January 13, 2020. The NDUFAF4 gene encodes NADH:ubiquinone oxidoreductase (complex I) assembly factor 4. The NDUFAF4 gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2017 (PMID: 28853723). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included one homozygous variant identified in one case in one publication (PMID: 28853723). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, expression, functional alteration in patient cells, and rescue in patient cells (PMIDs: 18179882, 25613900, 23670274). In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on January 13, 2020 (SOP Version 7).

mitochondrial complex I deficiency, nuclear type 15STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0032620

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Mitochondrial complex I deficiency, nuclear type 15AR

Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Comments: Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may have cardiac involvement

Refs: 11743516; 18179882Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to NDUFAF4 variants in ClinVar

7 Conditions Cataloged
not providedTotal: 50
Inborn genetic diseasesTotal: 20
Mitochondrial complex I deficiency, nuclear type 1Total: 10
not specifiedTotal: 9
Mitochondrial complex I deficiency, nuclear type 15Total: 6
NDUFAF4-related disorderTotal: 1
Mitochondrial complex I deficiencyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014165.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
15
clinvar
1
clinvar
18
missense
1
clinvar
2
clinvar
35
clinvar
5
clinvar
1
clinvar
44
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
Total124020265

Highest pathogenic variant AF is 0.0000013681594

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 19 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014165.4RefSeqNP_054884.13MANE Select
ENST00000316149.8EnsemblENSP00000358272.43MANE Select
ENST00000872119.1EnsemblENSP00000542178.13Standard
ENST00000872119.2EnsemblENSP00000542178.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Thermogenesis - Homo sapiens (human)
  • Respiratory electron transport
  • The citric acid (TCA) cycle and respiratory electron transport
  • Metabolism
  • Complex I biogenesis

Biological Process

  • mitochondrial respiratory chain complex I assembly

Molecular Function

  • protein binding
  • calmodulin binding

Cellular Component

  • mitochondrion
  • mitochondrial inner membrane
  • mitochondrial membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000316149
Coding exons
3
Length
8569
Individuals with no LoFs
125744
Homozygous LoFs
0
Heterozygous LoFs
4
Defined
125748
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.06269091.70.9820.000004511154
Missense (PolyPhen)2426.490.90602337
Synonymous-0.3833734.21.080.00000176324
Loss of Function2.0216.610.1512.91e-780

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000350.000035rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). May be involved in cell proliferation and survival of hormone-dependent tumor cells. May be a regulator of breast tumor cell invasion. {ECO:0000269|PubMed:14871833, ECO:0000269|PubMed:17001319, ECO:0000269|PubMed:18179882}.;
Disease
DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:18179882}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0942

Intolerance Scores

LoFtool
0.198
RVIS EVS
0.01
RVIS percentile EVS
54.95

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.382

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.